首页> 外文期刊>World Journal of Gastroenterology >Nonalcoholic steatohepatitis in Asian Indians is neither associated with iron overload nor with HFE gene mutations.
【24h】

Nonalcoholic steatohepatitis in Asian Indians is neither associated with iron overload nor with HFE gene mutations.

机译:亚洲印第安人的非酒精性脂肪性肝炎与铁超载或HFE基因突变均无关。

获取原文
获取原文并翻译 | 示例
       

摘要

AIM: The pathogenesis of occurrence of liver inflammation and fibrosis in patients with nonalcoholic steatohepatitis (NASH) is not completely understood. Other than insulin resistance, iron abnormalities have been thought to be one of the triggering factors. Therefore, our aim was to study the role of iron abnormalities and HFE gene mutations in patients with NASH. METHODS: Thirty-one patients of NASH diagnosed on the basis of clinical examination biochemistry, ultrasonography and liver biopsy (n = 14) were included in the study. Serum iron parameters (n = 23) (iron, ferritin, total iron-binding capacity and transferrin saturation), Perls' iron staining on liver biopsies (n = 14) and HFE gene mutations (C282Y and H63D) (n = 16) were studied in these patients. The association between iron staining, necroinflammatory activity and fibrosis stage on liver biopsies was also determined. RESULTS: Elevated serum iron, ferritin and transferrin saturation above 55% were observed in 4.3% of patients. On histology, 71% of the patients had negative iron staining, 21.4% had 1+ staining, 7.2% had 2+ staining and none had 3+ or 4+ staining. There was no association between the degree of iron staining and necroinflammatory activity (P = 0.55) and fibrosis stage (P = 0.09) on histology. None of the patients had C282Y HFE gene mutation and four patients (25%) were found to be heterozygotes for H63D gene mutation. CONCLUSION: Our study does not favor iron overload and HFE gene mutations as major factors in the pathogenesis of NASH in Asian Indians.
机译:目的:尚未完全了解非酒精性脂肪性肝炎(NASH)患者肝脏炎症和纤维化发生的发病机理。除胰岛素抵抗外,铁异常被认为是触发因素之一。因此,我们的目的是研究铁异常和HFE基因突变在NASH患者中的作用。方法:根据临床检查生化,超声检查和肝活检诊断为NASH的31例患者(n = 14)被纳入研究。血清铁参数(n = 23)(铁,铁蛋白,总铁结合能力和转铁蛋白饱和度),肝活检标本的Perls铁染色(n = 14)和HFE基因突变(C282Y和H63D)(n = 16)为在这些患者中进行了研究。还确定了肝活检中铁染色,坏死性炎症活性和纤维化阶段之间的关系。结果:4.3%的患者血清铁,铁蛋白和转铁蛋白饱和度高于55%。在组织学上,71%的患者铁染色为阴性,21.4%的患者为1+染色,7.2%的患者为2+染色,无3+或4+染色。组织学上铁染色的程度和坏死性炎症活性(P = 0.55)与纤维化阶段(P = 0.09)之间没有关联。没有患者发生C282Y HFE基因突变,并且发现四名患者(25%)是H63D基因突变的杂合子。结论:我们的研究不赞成将铁超载和HFE基因突变作为亚洲印第安人NASH发病机理的主要因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号